Your session is about to expire
← Back to Search
kTMP Brain Stimulation for Healthy Individuals (SBIR_2022 Trial)
N/A
Waitlist Available
Research Sponsored by Magnetic Tides
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up measures will be obtained from 0 to 15 minutes before the stimulation.
Awards & highlights
SBIR_2022 Trial Summary
This trial will explore a new non-invasive brain stimulation system to safely modulate specific areas of the brain for therapeutic effects.
Who is the study for?
This trial is for healthy individuals aged 18-75 who haven't had a highly stressful event in the past day. It's not suitable for those with metal head implants (except dental), pregnancy, serious medical conditions, neurological disorders, brain surgery history, pacemakers, substance abuse issues, seizures or epilepsy history, head injuries or stroke survivors.Check my eligibility
What is being tested?
The study tests kTMP—a new non-invasive brain stimulation system—against a sham (fake) version to see how well it works and how tolerable it is. The goal is to find out if this device can safely change brain activity without causing harm.See study design
What are the potential side effects?
Since kTMP is designed to modulate neural excitability in the brain without making physical contact, potential side effects may include discomfort at the stimulation site or headaches but will be closely monitored.
SBIR_2022 Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ measures will be obtained from 0 to 15 minutes before the stimulation.
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~measures will be obtained from 0 to 15 minutes before the stimulation.
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Motor evoked potential (MEPs) amplitude recorded with EMG after kTMP stimulation.
Motor evoked potential (MEPs) amplitude recorded with electromyography (EMG) before kTMP stimulation.
Self-reported sensation/discomfort through questionnaire after kTMP stimulation.
+1 moreSBIR_2022 Trial Design
2Treatment groups
Experimental Treatment
Placebo Group
Group I: active kTMPExperimental Treatment1 Intervention
Participants received 0.5 - 8 V/m of active stimulation.
Group II: sham kTMPPlacebo Group2 Interventions
Participants received 0.01 V/m of sham stimulation.
Find a Location
Who is running the clinical trial?
Magnetic TidesLead Sponsor
1 Previous Clinical Trials
15 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have had a stroke in the past.I have been diagnosed with epilepsy or have had seizures.I have a neurological disorder.I have a history of migraines.I have had brain surgery in the past.I have a history of seizures.I have broken or abnormal skin on my scalp.I am between 18 and 75 years old.I have metal implants in my head, but not in my mouth.I have hearing loss.
Research Study Groups:
This trial has the following groups:- Group 1: active kTMP
- Group 2: sham kTMP
Awards:
This trial has 0 awards, including:Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Could I potentially participate in this trial?
"This research requires that potential participants are in good health and between the ages of 18 to 75. All told, 150 volunteers need to be recruited for this scientific endeavour."
Answered by AI
Are there still openings for participants in this study?
"The information on clinicaltrials.gov affirms that this trial is no longer enrolling participants, having been initially posted on August 16th 2022 and last updated July 15th 2023. Nevertheless, there are presently 807 trials recruiting patients from various locations."
Answered by AI
Does this clinical experiment have an age limitation, and if so, what is it?
"Patients aged 18 to 75 are eligible for this trial. Additionally, 56 trials provide support for those younger than 18 and 378 studies exist with a focus on individuals above 65 years old."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger